Hazard ratios (HR) and 95% Confidence Interval (CI) for progression-free survival (PFS) for studies included in the indirect treatment comparison for cabazitaxel, abiraterone acetate and enzalutamide.
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
官方服务：
资源简介：
Hazard ratios (HR) and 95% Confidence Interval (CI) for progression-free survival (PFS) for studies included in the indirect treatment comparison for cabazitaxel, abiraterone acetate and enzalutamide.
本数据集收录了卡巴他赛（cabazitaxel）、醋酸阿比特龙（abiraterone acetate）与恩扎卢胺（enzalutamide）的间接治疗比较所纳入的各项研究的无进展生存期（Progression-Free Survival, PFS）风险比（Hazard Ratio, HR）及95%置信区间（Confidence Interval, CI）
创建时间：
2018-04-12
